Showing results (1401-1410 of 1,799) with videos related to
Sort By:
Pageof 180
Mabs|June 18, 2013
The human natural killer cytotoxic cell line NK-92, once armed with a murine CD16 receptor, represents a convenient cellular tool for the screening of mouse mAbs according to their ADCC potentialBéatrice Clémenceau, Régine Vivien, Catherine Pellat, et al.Mabs|April 9, 2013
Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometryRabah Gahoual, Alicia Burr, Jean-Marc Busnel, et al.Mabs|June 19, 2013
Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgGXiangdan Wang, Valerie Quarmby, Carl Ng, et al.Mabs|June 19, 2013
Expression of antibodies using single open reading frame (sORF) vector design: Demonstration of manufacturing feasibilityWendy R Gion, Rachel A Davis-Taber, Dean A Regier, et al.Mabs|March 27, 2013
Agonistic TAM-163 antibody targeting tyrosine kinase receptor-B: applying mechanistic modeling to enable preclinical to clinical translation and guide clinical trial designYulia Vugmeyster, Cynthia Rohde, Mylene Perreault, et al.Mabs|January 5, 2010
Two doses of humanized anti-CD25 antibody in renal transplantation: a preliminary comparative studyJing Li, Xinyan Li, Min Tan, et al.Mabs|January 5, 2010
How can we improve antibody-based cancer therapy?Li Yan, Paula J Ehrlich, Raymond Gibson, et al.Mabs|January 13, 2010
Second International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA USAJanice M Reichert, Nitya Jacob, Ashraf AmanullahMabs|January 13, 2010
European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UKJanice M Reichert, Alain Beck, Harish IyerPageof 180